NFE2L2 and pancreatic intraductal papillary-mucinous neoplasm: Although NRF2 is widely recognized for its antioxidant functions (38), our findings showed that conventional approaches to alter intrapancreatic ROS levels did not affect IPMN incidence in KCN mice.